Consensus Avanos Medical, Inc.

Equities

AVNS

US05350V1061

Market Closed - Nyse Other stock markets 21:00:02 30/04/2024 BST			5-day change	1st Jan Change
18.08 ^USD	-2.90%		-3.62%	-19.39%

02-22	Avanos Medical, Inc. Announces Voluntary Recall of Mic Gastric - Jejunal Feeding Tube Kits	CI
02-21	Tranche Update on Avanos Medical, Inc.'s Equity Buyback Plan announced on August 1, 2023.	CI

Evolution of the average Target Price on Avanos Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0f.IeGsk1HF_ru5YXBNmEK0x8hNLHN_TPFkCrwsGPLd-mQ.WYnI5R79vN3UAwIE6SHgobg9YxsTB7UOYvh_c6HwtlFQgPXfPIy309AgRA~27851f03204eef80b830eab649a4f269

Analyst Recommendations on Avanos Medical, Inc.

KeyBanc Downgrades Avanos Medical to Sector Weight From Overweight on 'Uncertain' Near-Term Outlook, Lack of Upside Catalysts	25/07/23	MT
CL King Initiates Avanos Medical at Buy Rating With $31 Price Target	22/05/23	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $26 From $28, Keeps Underweight Rating	04/05/23	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $26, Maintains Underweight Rating	22/02/23	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $26 From $24, Maintains Underweight Rating	06/01/23	MT
KeyBanc Adjusts Avanos Medical' Price Target to $34 From $38, Keeps Overweight Rating	03/11/22	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $24 From $28, Reiterates Underweight Rating	11/10/22	MT
KeyBanc Adjusts Avanos Medical's Price Target to $38 from $41, Keeps Overweight Rating	10/08/22	MT
Stifel Nicolaus Adjusts Avanos Medical's Price Target to $28 From $37, Maintains Hold Rating	18/07/22	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $33, Maintains Underweight Rating	15/07/22	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $33 from $36, Keeps Underweight Rating	05/05/22	MT
KeyBanc Adjusts Avanos Medical's Price Target to $41 From $47, Maintains Overweight Rating	24/02/22	MT
Berenberg Bank Terminates Coverage on a Number of Companies Due to Analysts' Departures From the Firm	13/12/21	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Price Target on Avanos Medical to $41 From $45, Maintains Underweight Rating	04/08/21	MT
AVANOS MEDICAL : Berenberg Bank Adjusts Avanos Medical PT to $45 From $50, Maintains Buy Rating	04/08/21	MT
AVANOS MEDICAL : Stephens Cuts Avanos Medical to Equal-Weight From Overweight, Price Target to $45 From $60	04/08/21	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $55, Keeps Overweight Rating	04/08/21	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $45 from $36, Keeps Underweight Rating	15/12/20	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $43, Keeps at Overweight	04/11/20	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $36 From $31, Keeps Underweight Rating	04/11/20	MT
Halyard Health, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Tax Rate Guidance for the Year 2018	27/02/18	CI

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

18.08 USD

Average target price

23.5 USD

Spread / Average Target

+29.98%

High Price Target

27 USD

Spread / Highest target

+49.34%

Low Price Target

20 USD

Spread / Lowest Target

+10.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Avanos Medical, Inc.

KeyBanc Capital Markets
CL King
Morgan Stanley
Stifel Nicolaus
Stephens Inc.
Berenberg Bank

Quarterly earnings - Rate of surprise

Company calendar